… "I want to create information that's going to help everyone." Anne Wojcicki, CEO of consumer genetics company 23andMe, spoke these words in a  recent interview on the "Today Show ." 23andMe is well known for helping people uncover …

… (PD) advocates from nearly all 50 states convened in Washington, D.C. for the 2018 Parkinson's Policy Forum. This annual … streets of Washington, advocates made sure the Parkinson's community was heard on Capitol Hill. This year's Forum was … and care partners. Attendees also received training on how to build relationships with lawmakers and be an …

… is when you act out dreams while asleep. It’s a risk factor for Parkinson’s disease, and many people with … I had my first sleep study and examination, and learned how powerful participating in research can be. I am very … San Francisco Bay Area, who prescribed melatonin. With the combination of that and other aids, I find that my symptoms …

… Iron in the substantia nigra is an etiological factor in PD. In addition, iron is established as a key … with induction of oxidative stress. Numerous studies have shown that oxidative stress is the leading cause of cell … strategies for neurotoxin exposure and PD. Final Outcome Dr. Connor examined models with reduced H-ferritin …

… For years I’ve been hesitant to assign what I thought was a high amount — $1.5 billion — … analysis from Matt Herper, author of a popular Forbes.com blog , found small pharmaceutical companies spend $950 … high cost of drug development. Why are we so concerned with how much it costs to make a drug? Pharmaceutical companies’ …

… substantia nigra in Parkinson's disease remains unknown. However, one feature of the degenerative process is the onset of inflammation in this brain region due to the activation of another type of cell known as glia. … the survival of the dopaminergic neurons, but when they become activated they start to secrete many different kinds of …